Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11680090 Interleukin-2 fusion proteins and uses thereof

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Current Assignee
Medicenna Therapeutics Corp.
Medicenna Therapeutics Corp.
0
Date Filed
August 12, 2020
0
Date of Patent
June 20, 2023
0
Patent Applicant
Medicenna Therapeutics Corp.
Medicenna Therapeutics Corp.
0
Patent Application Number
16992068
0
Patent Citations
‌
US Patent 8337850 4-1BB binding molecules
0
‌
US Patent 8962804 Meditopes and meditope-binding antibodies and uses thereof
0
‌
US Patent 9428567 Antagonists of interleukin-2 receptor
0
‌
US Patent 10781242 Interleukin-2 fusion proteins and uses thereof
0
‌
US Patent 9468678 Method of producing 4-1BB binding molecules and associated nucleic acids
0
‌
US Patent 7569215 Mutant interleukin-2 (IL-2) polypeptides
0
‌
US Patent 7741465 Chimeric receptor genes and cells transformed therewith
0
‌
US Patent 7943743 Human monoclonal antibodies to programmed death ligand 1 (PD-L1)
0
‌
US Patent 8008449 Human monoclonal antibodies to programmed death 1 (PD-1) and methods for treating cancer using anti-PD-1 antibodies alone or in combination with other immunotherapeutics
0
‌
US Patent 8217149 Anti-PD-L1 antibodies, compositions and articles of manufacture
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
11680090
0
Patent Primary Examiner
‌
Bridget E Bunner
0
CPC Code
‌
A61K 38/1761
0
‌
A61K 38/20
0
‌
C07K 14/55
0
‌
A61K 38/2013
0
‌
C07K 14/47
0
‌
C07K 14/4747
0
‌
C07K 14/54
0
‌
A61K 38/17
0

Find more entities like US Patent 11680090 Interleukin-2 fusion proteins and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo